#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Haemophilia B with anti factor IX Dedifferentiated liposarcoma Primary biliary cholangitis Enteritis Infective uveitis Squamous cell carcinoma of head and neck Immunodeficiency common variable Hereditary ataxia Growth hormone deficiency Ventricular tachycardia Chronic lymphocytic leukaemia refractory Hepatic angiosarcoma Arrhythmia Burkitt's lymphoma refractory Ureteric cancer More trials…

    Learn about Rare Diseases

    Gaucher’s disease type I Soft tissue sarcoma – Basic Information Advanced systemic mastocytosis – Life with Disease Cholangitis sclerosing – Trials in Disease Crigler-Najjar syndrome – Life with Disease Mastocytosis – Treatment Osteosarcoma Nodal marginal zone B-cell lymphoma – Trials in Disease Basal cell naevus syndrome – Basic Information Systemic mastocytosis – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Tafamidis GOCATAMIG Ivermectin Rocuronium Bromide MZE829 Acasunlimab Rilpivirine Calcium Chloride Mannitol Sulpiride Samuraciclib Cobolimab Zanamivir Furosemide Belinostat Lacosamide Eptinezumab Tertomotide Glucose Monohydrate XELAFASLATIDE More therapies…

    Learn about Your Condition

    Underweight Lymphatic malformation Tinnitus Radicular pain Krabbe's disease Transient ischaemic attack Lung adenocarcinoma Left ventricular failure Thyroid cancer metastatic Breast cancer metastatic Spinal osteoarthritis Meningococcal infection Choroid melanoma Lung neoplasm malignant Cholangiocarcinoma More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Musculoskeletal Diseases

  • Comparing ropivacaine and bupivacaine for pain relief after hip replacement surgery in patients with hip osteoarthritis

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Hip arthroplasty
    • Procedural pain
    • Osteoarthritis
    Investigated Drugs:
    • Bupivacaine Hydrochloride
    • Ropivacaine Hydrochloride
    Finland

  • Study of B Cell Response to Tetanus Toxoid Vaccination in Patients with Systemic Sclerosis, Systemic Lupus Erythematosus, and Rheumatoid Arthritis

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Systemic lupus erythematosus
    • Rheumatoid arthritis
    • Systemic scleroderma
    Investigated Drugs:
    • TETANUS TOXOID
    The Netherlands

  • Evaluation of BIO-101 versus placebo for treating severe sarcopenia in elderly patients with reduced mobility

    Not yet recruiting

    3 1
    Investigated Drugs:
    • 20-HYDROXYECDYSONE
    Belgium

  • Study of RSV vaccines Arexvy and Abrysvo in patients with inflammatory rheumatic diseases receiving anti-rheumatic treatments

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Giant cell arteritis
    • Polymyalgia rheumatica
    • Systemic lupus erythematosus
    Investigated Drugs:
    • Respiratory Syncytial Virus, Glycoprotein F, Recombinant, Stabilised In The Pre-Fusion Conformation, Adjuvanted With As01E
    Sweden

  • Study of botulinum toxin injections to treat pain in patients with piriformis muscle syndrome

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Piriformis syndrome
    Investigated Drugs:
    • Clostridium Botulinum Neurotoxin Type A (150Kd), Free Of Complexing Proteins
    France

  • Study of tocilizumab compared to placebo in patients with chronic chondrocalcinosis who did not respond to standard treatments

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Chondrocalcinosis
    Investigated Drugs:
    • Sodium Chloride
    • Tocilizumab
    France
Previous Page
1 … 33 34 35 36 37 … 67
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!